Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Neurometrix Inc (NURO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 6,801
  • Shares Outstanding, K 10,150
  • Annual Sales, $ 12,030 K
  • Annual Income, $ -14,910 K
  • 36-Month Beta 0.29
  • Price/Sales 0.53
  • Price/Cash Flow 0.00
  • Price/Book 0.91
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -7.67
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 04/20/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.15 on 03/28/07
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.52 +28.85%
on 04/07/17
0.73 -8.22%
on 04/19/17
+0.04 (+6.35%)
since 03/21/17
3-Month
0.52 +28.85%
on 04/07/17
0.84 -20.24%
on 01/26/17
-0.04 (-5.63%)
since 01/20/17
52-Week
0.52 +28.85%
on 04/07/17
2.36 -71.61%
on 06/03/16
-1.15 (-63.19%)
since 04/21/16

Most Recent Stories

More News
NeuroMetrix, Inc. Announces Date for 2017 First Quarter Financial Results Conference Call

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2017 first quarter financial results before the opening of the market on Thursday, April 20, 2017. The Company...

NURO : 0.67 (+6.35%)
NeuroMetrix Brings Quell Wearable for Pain Relief to American Academy of Pain Medicine 33rd Annual Meeting

Coming together with thousands of leading clinicians who treat patients with chronic pain, NeuroMetrix, Inc. (Nasdaq: NURO) will exhibit Quell(R), its FDA-cleared, 100% drug-free wearable...

NURO : 0.67 (+6.35%)
NeuroMetrix Reports Strong Quell Demand in Q4 2016

NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO, NUROW) reported Q4 2016 demand highlights for its Quell(R) Wearable Pain Relief Technology(TM). During Q4 2016 the invoiced value of Quell...

NURO : 0.67 (+6.35%)
NeuroMetrix to Present at the Digital Medicine Showcase 2017: At the Intersection of Technology and Medicine

NeuroMetrix, Inc. (NASDAQ:NURO, NUROW) today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Digital Medicine Showcase 2017...

NURO : 0.67 (+6.35%)
CES 2017: NeuroMetrix Brings Life-Enhancing Technology to Those Suffering from Chronic Pain

NeuroMetrix, Inc. (Nasdaq:NURO, NUROW) today announced plans to unveil important advances to its Quell(R) Wearable Pain Relief Technology(TM) at CES 2017 (CES Unveiled, Table 128 and...

NURO : 0.67 (+6.35%)
NeuroMetrix Announces $7.0 Million Private Placement of Preferred Stock and Warrants

NeuroMetrix, Inc. (NASDAQ: NURO, NUROW) announced today that it has entered into a definitive securities purchase agreement with a healthcare dedicated institutional investor in connection...

NURO : 0.67 (+6.35%)
NeuroMetrix Reports Expanded Media Coverage for Quell Wearable Pain Relief

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) reported increased media attention on the company's Quell(R) Wearable Pain Relief Technology(TM), including an in depth report on CBS's Innovation...

NURO : 0.67 (+6.35%)
NeuroMetrix Announces That Quell Is Featured in Huffington's New Thrive Global Platform

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that its Quell(R) Wearable Pain Relief Technology(TM) is featured in the new Thrive Global commerce platform, including the online...

NURO : 0.67 (+6.35%)
NeuroMetrix President and Chief Executive Officer Dr. Gozani to Speak at 2016 Connected Health Conference

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that Shai N. Gozani, M.D., Ph.D., President and CEO of NeuroMetrix will speak on using personal connected health for pain, addiction,...

NURO : 0.67 (+6.35%)
NeuroMetrix Receives CE Mark Certification for Quell Wearable Pain Relief Device

NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that the CE (Conformite Europeenne) Certificate for Quell(R) has been received from TA deg V SA deg D Product Service GmbH, which is...

NURO : 0.67 (+6.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Business Summary

Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes,...

See More

Support & Resistance

2nd Resistance Point 0.74
1st Resistance Point 0.71
Last Price 0.67
1st Support Level 0.61
2nd Support Level 0.54

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.